Huntington's disease: a clinical review

P McColgan, SJ Tabrizi - European journal of neurology, 2018 - Wiley Online Library
Huntington's disease (HD) is a fully penetrant neurodegenerative disease caused by a
dominantly inherited CAG trinucleotide repeat expansion in the huntingtin gene on …

Clinical neurology and epidemiology of the major neurodegenerative diseases

MG Erkkinen, MO Kim… - Cold Spring Harbor …, 2018 - cshperspectives.cshlp.org
Neurodegenerative diseases are a common cause of morbidity and cognitive impairment in
older adults. Most clinicians who care for the elderly are not trained to diagnose these …

Vascular contributions to Alzheimer's disease

LB Eisenmenger, A Peret, BM Famakin, A Spahic… - Translational …, 2023 - Elsevier
Alzheimer's disease (AD) is the most common cause of dementia and is characterized by
progressive neurodegeneration and cognitive decline. Understanding the pathophysiology …

World Health Organization disability assessment schedule 2.0: An international systematic review

S Federici, M Bracalenti, F Meloni… - Disability and …, 2017 - Taylor & Francis
Purpose: This systematic review examines research and practical applications of the World
Health Organization Disability Assessment Schedule (WHODAS 2.0) as a basis for …

Polyglutamine repeats in neurodegenerative diseases

AP Lieberman, VG Shakkottai… - Annual Review of …, 2019 - annualreviews.org
Among the age-dependent protein aggregation disorders, nine neurodegenerative diseases
are caused by expansions of CAG repeats encoding polyglutamine (polyQ) tracts. We …

Research domain criteria: strengths, weaknesses, and potential alternatives for future psychiatric research

CA Ross, RL Margolis - Complex Psychiatry, 2019 - karger.com
Abstract The Research Domain Criteria (RDoC) paradigm was launched 10 years ago as a
superior approach for investigation of mental illness. RDoC conceptualizes normal human …

Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases

M Benatar, J Wuu, C McHutchison, RB Postuma… - Brain, 2022 - academic.oup.com
Significant progress has been made in understanding the pre-symptomatic phase of
amyotrophic lateral sclerosis. While much is still unknown, advances in other …

Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease

FB Rodrigues, LM Byrne, R Tortelli… - Science translational …, 2020 - science.org
The longitudinal dynamics of the most promising biofluid biomarker candidates for
Huntington's disease (HD)—mutant huntingtin (mHTT) and neurofilament light (NfL)—are …

Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis

C Fusilli, S Migliore, T Mazza, F Consoli… - The Lancet …, 2018 - thelancet.com
Background Huntington's disease is a rare, neurodegenerative disease caused by an
expanded CAG repeat mutation in the huntingtin gene. Compared with adult-onset …

[HTML][HTML] Movement disorder society task force viewpoint: Huntington's disease diagnostic categories

CA Ross, R Reilmann, F Cardoso… - Movement disorders …, 2019 - ncbi.nlm.nih.gov
Huntington's disease (HD) is traditionally considered as a triad of movement, cognitive, and
emotional disorders. 1–4 According to current clinical practice,“manifest HD” is diagnosed …